Discover open access scientific publications

Search, annotate, share and cite publications

Publications by S. MacKnight

REAL-WORLD HEALTHCARE RESOURCE UTILIZATION (HRU) OF CLASSICAL HODGKIN LYMPHOMA (cHL) PATIENTS (PTS) TREATED WITH ANTI-PD1 CHECKPOINT INHIBITORS IN THE UNITED STATES (US)

Hematological Oncology

English

Related publications

Retreatment With Nivolumab in Patients With R/R Classical Hodgkin Lymphoma After Discontinuation of the Therapy With Immune Checkpoint Inhibitors

Hematological Oncology

English

Persistence, Dose Titration, and Health Care Resource Utilization Among Crohn’s Disease Patients Treated With Ustekinumab: A Real-World Analysis in the United States

English

EXPRESS: Treatment Patterns, Healthcare Resource Utilization, and Healthcare Costs Among Patients With Pulmonary Arterial Hypertension in a Real-World US Database

Pulmonary Circulation

Pulmonary

Respiratory Medicine

2018

English

Leucocyte and Eosinophil Counts Predict Progression-Free Survival in Relapsed or Refractory Classical Hodgkin Lymphoma Patients Treated With PD1 Inhibition

British Journal of Haematology

Hematology

2017

English

Real World Annualized Healthcare Utilization and Expenditures Among Insured US Patients With Acute Intermittent Porphyria (AIP) Treated With Hemin

Journal of Medical Economics

Health Policy

2020

English

Real-World Productivity, Healthcare Resource Utilization (Hru), and Quality of Life (Qol) in Patients With First-Line Advanced Gastric Cancer (Agc) in Korea and Japan

English

Healthcare Resource Utilization and Costs in Amyloid Light-Chain Amyloidosis: A Real-World Study Using US Claims Data

Journal of Comparative Effectiveness Research

Health Policy

2018

English

Biomarkers and Outcomes in Omalizumab-Treated Patients With Allergic Asthma: A Real-World Study in a Large Allergy Practice in the United States (US)

Journal of Allergy and Clinical Immunology

Allergy

Immunology

2019

English

Health Care Resource Utilization and Costs of Patients With Aspergillosis in the United States

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by S. MacKnight

REAL-WORLD HEALTHCARE RESOURCE UTILIZATION (HRU) OF CLASSICAL HODGKIN LYMPHOMA (cHL) PATIENTS (PTS) TREATED WITH ANTI-PD1 CHECKPOINT INHIBITORS IN THE UNITED STATES (US)

Related publications

Retreatment With Nivolumab in Patients With R/R Classical Hodgkin Lymphoma After Discontinuation of the Therapy With Immune Checkpoint Inhibitors

Persistence, Dose Titration, and Health Care Resource Utilization Among Crohn’s Disease Patients Treated With Ustekinumab: A Real-World Analysis in the United States

EXPRESS: Treatment Patterns, Healthcare Resource Utilization, and Healthcare Costs Among Patients With Pulmonary Arterial Hypertension in a Real-World US Database

Leucocyte and Eosinophil Counts Predict Progression-Free Survival in Relapsed or Refractory Classical Hodgkin Lymphoma Patients Treated With PD1 Inhibition

Real World Annualized Healthcare Utilization and Expenditures Among Insured US Patients With Acute Intermittent Porphyria (AIP) Treated With Hemin

Real-World Productivity, Healthcare Resource Utilization (Hru), and Quality of Life (Qol) in Patients With First-Line Advanced Gastric Cancer (Agc) in Korea and Japan

Healthcare Resource Utilization and Costs in Amyloid Light-Chain Amyloidosis: A Real-World Study Using US Claims Data

Biomarkers and Outcomes in Omalizumab-Treated Patients With Allergic Asthma: A Real-World Study in a Large Allergy Practice in the United States (US)

Health Care Resource Utilization and Costs of Patients With Aspergillosis in the United States